Your browser doesn't support javascript.
loading
Neoadjuvant Chemotherapy Use for Nonmetastatic Breast Cancer at Five Public South African Hospitals and Impact on Time to Initial Cancer Therapy.
O'Neil, Daniel S; Nietz, Sarah; Buccimazza, Ines; Singh, Urishka; Cacala, Sharon; Stopforth, Laura W; Joffe, Maureen; Jacobson, Judith S; Neugut, Alfred I; Crew, Katherine D; Ruff, Paul; Cubasch, Herbert.
Affiliation
  • O'Neil DS; Herbert Irving Comprehensive Cancer Center, Columbia University, New York New York, USA dso2116@cumc.columbia.edu.
  • Nietz S; Department of Medicine, College of Physicians and Surgeons, Columbia University, New York New York, USA.
  • Buccimazza I; Noncommunicable Diseases Research Division, Wits Health Consortium (PTY) Ltd, Johannesburg, Gauteng, South Africa.
  • Singh U; Department of Surgery, Charlotte Maxeke Johannesburg Academic Hospital, University of Witwatersrand, Johannesburg, Gauteng, South Africa.
  • Cacala S; Noncommunicable Diseases Research Division, Wits Health Consortium (PTY) Ltd, Johannesburg, Gauteng, South Africa.
  • Stopforth LW; Departments of Surgery and Oncology, Inkosi Albert Luthuli Central Hospital, Durban and Ngwelezane Hospital, University of KwaZulu-Natal, Empangeni, KwaZulu-Natal, South Africa.
  • Joffe M; Noncommunicable Diseases Research Division, Wits Health Consortium (PTY) Ltd, Johannesburg, Gauteng, South Africa.
  • Jacobson JS; Departments of Surgery and Oncology, Inkosi Albert Luthuli Central Hospital, Durban and Ngwelezane Hospital, University of KwaZulu-Natal, Empangeni, KwaZulu-Natal, South Africa.
  • Neugut AI; Noncommunicable Diseases Research Division, Wits Health Consortium (PTY) Ltd, Johannesburg, Gauteng, South Africa.
  • Crew KD; Departments of Surgery and Oncology, Grey's Hospital, University of KwaZulu-Natal, Pietermaritzburg, KwaZulu-Natal, South Africa.
  • Ruff P; Noncommunicable Diseases Research Division, Wits Health Consortium (PTY) Ltd, Johannesburg, Gauteng, South Africa.
  • Cubasch H; Departments of Surgery and Oncology, Grey's Hospital, University of KwaZulu-Natal, Pietermaritzburg, KwaZulu-Natal, South Africa.
Oncologist ; 24(7): 933-944, 2019 07.
Article in En | MEDLINE | ID: mdl-30518615
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Neoadjuvant Therapy / Time-to-Treatment / Hospitals, Public Type of study: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Middle aged Country/Region as subject: Africa Language: En Journal: Oncologist Journal subject: NEOPLASIAS Year: 2019 Document type: Article Affiliation country: United States Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Neoadjuvant Therapy / Time-to-Treatment / Hospitals, Public Type of study: Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Female / Humans / Middle aged Country/Region as subject: Africa Language: En Journal: Oncologist Journal subject: NEOPLASIAS Year: 2019 Document type: Article Affiliation country: United States Country of publication: United kingdom